SFRP4 and leiomyoma: In our initial whole genome transcriptional profiling, sFRP4 expression was both 2.6 times greater in fibroids as compared with myometrium (P < 0.01) and 2.5 times greater in leiomyomas collected in the proliferative phase than specimens collected during the luteal phase (P < 0.01).